Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine for acute suicidality (double-blind randomized placebo-controlled trial)
2015-004745-70Phase 2Active
- Sponsor
- Academic Medical Center
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in suicidal ideation comparing Intranasal ketalar 50 mg with Intranasal midazolam 4.5 mg (placebo control) (2 arms). Started Aug 2018; status: active.
02
Drugs
ketamine
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on 2015-004745-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004745-70.